CASI Pharmaceuticals (CASIF) Other Operating Expenses (2022 - 2025)
CASI Pharmaceuticals' (CASIF) quarterly Other Operating Expenses came in at $5.7 million in Q4 2025, up 27323.81% YoY from N/an in Q4 2024, and up 213.37% on a QoQ basis from -$5.0 million in Q3 2025.
CASI Pharmaceuticals (CASIF) Other Operating Expenses (2022 - 2025) Analysis & Trends
CASI Pharmaceuticals (CASIF) has 4 years of Other Operating Expenses data on file, last reported at $5.7 million in Q4 2025.
- Quarterly Other Operating Expenses rose 27323.81% year-over-year to $5.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.7 million (down 34.48% YoY) and the FY2025 annual result came in at $20.5 million, up 4180.58% from the prior year.
- Other Operating Expenses rose to $5.7 million in Q4 2025, from -$5.0 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $5.7 million in Q4 2025 to a low of -$29.8 million in Q4 2022.
- A 4-year average of -$1.8 million and a median of $500000.0 in 2024 frame the typical range for Other Operating Expenses.
- The widest YoY moves for Other Operating Expenses: up 27323.81% in 2025, down 1175.0% in 2025.
- Tracing CASIF's Other Operating Expenses over 4 years: stood at -$29.8 million in 2022, then jumped by 73.69% to -$7.8 million in 2023, then soared by 99.73% to -$21000.0 in 2024, then soared by 27323.81% to $5.7 million in 2025.
- The last three Other Operating Expenses figures came in at $5.7 million (Q4 2025), -$5.0 million (Q3 2025), and -$5.4 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CASI Pharmaceuticals | 2.65 Mn | -3.76 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.72 Mn |
| Sep 30, 2025 | -5.04 Mn |
| Jun 30, 2025 | -5.38 Mn |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | -21,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | -3.97 Mn |
| Dec 31, 2023 | -7.84 Mn |
| Sep 30, 2023 | 2.37 Mn |
| Jun 30, 2023 | 4.86 Mn |
| Mar 31, 2023 | 3.90 Mn |
| Dec 31, 2022 | -29.78 Mn |
| Sep 30, 2022 | 2.93 Mn |
| Jun 30, 2022 | 2.04 Mn |
| Mar 31, 2022 | 2.94 Mn |